Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases

Alzheimer’s disease (AD) is a neurodegenerative disease with a high incidence rate and complicated pathogenesis. Currently, all anti-AD drugs treat the symptoms of the disease, and with currently no cure for AD. Flavonoid containing natural products, Myricetin (MYR) and Dihydromyricetin (DMY), are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Miaomiao, Guo, Hong, Li, Zhongyuan, Zhang, Chenghua, Zhang, Xiaoping, Cui, Qinghua, Tian, Jingzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645199/
https://www.ncbi.nlm.nih.gov/pubmed/33192493
http://dx.doi.org/10.3389/fnagi.2020.601603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645199/
https://www.ncbi.nlm.nih.gov/pubmed/33192493
http://dx.doi.org/10.3389/fnagi.2020.601603

Ejemplares similares